Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature currently requires accessing the site using the built-in Safari browser.
You are using an out of date browser. It may not display this or other websites correctly. You should upgrade or use an alternative browser.
Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page
They are hiring DNs now to carry the bag and try to penetrate academic centers. The DMs will begin hiring their teams in the 1st quarter.
No clinical studies yet but supposedly by using stackable codes they'll try to get reimbursement for the $5000 360 test -- heard it costs $450 to run. No Medicare reimbursement so they'll have to save those claims for later.
Not much other than no clinical data supporting use, use of stacked CPT codes, and suspect sales management and sales strategy --- academic centers --- hehehe
This company is nowhere near ready. They hired a bunch of folks but they will go nowhere.
I wonder what they told some of these people they hired. Guardant is a sure loser.
foundation has a lot of sales persons that were from other labs. they probably said BS to get their jobs especially old quest employees
her head is bigger than my......................
med centers internalizing more NGS assays and reimbursement continues to be a struggle
CMS showing no urgency in paying...what else can I do and they want MORE!!